Literature DB >> 14638511

In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model.

Pornpen Labthavikul1, Peter J Petersen, Patricia A Bradford.   

Abstract

The activity of tigecycline against Staphylococcus epidermidis growing in an in vitro adherent-cell biofilm model was determined. Tigecycline minimum bactericidal concentrations (MBCs) ranged from 1 to 8 microg/ml for S. epidermidis growing in a biofilm of adherent cells, compared to MBCs of 0.12 to >32 microg/ml for freely growing cells. The killing activity of tigecycline against the adherent bacteria was at least fourfold better than that of vancomycin and daptomycin.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14638511      PMCID： PMC296180          DOI： 10.1128/AAC.47.12.3967-3969.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

Review 1.  Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response.

Authors:  P Gilbert; P J Collier; M R Brown
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

2.  Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents.

Authors:  M Souli; H Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 3.  Resistance of bacterial biofilms to antibiotics: a growth-rate related effect?

Authors:  M R Brown; D G Allison; P Gilbert
Journal:  J Antimicrob Chemother       Date:  1988-12       Impact factor: 5.790

4.  Resistance of bacterial biofilms to antibiotics.

Authors:  C J Holmes; R C Evans
Journal:  J Antimicrob Chemother       Date:  1989-07       Impact factor: 5.790

5.  Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.

Authors:  G D Christensen; W A Simpson; J J Younger; L M Baddour; F F Barrett; D M Melton; E H Beachey
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

6.  In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.

Authors:  D J Biedenbach; M L Beach; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2001-08       Impact factor: 2.803

7.  In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens.

Authors:  Peter J Petersen; Patricia A Bradford; William J Weiss; Timothy M Murphy; P E Sum; Steven J Projan
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

8.  Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer.

Authors:  R C Evans; C J Holmes
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

9.  Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants.

Authors:  M Drancourt; A Stein; J N Argenson; A Zannier; G Curvale; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

10.  Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis.

Authors:  H Yasuda; Y Ajiki; T Koga; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191
View more
  15 in total

1.  In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection.

Authors:  C Silvestri; O Cirioni; D Arzeni; R Ghiselli; O Simonetti; F Orlando; G Ganzetti; S Staffolani; L Brescini; M Provinciali; A Offidani; M Guerrieri; A Giacometti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-11       Impact factor: 3.267

2.  Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters.

Authors:  Saima Aslam; Barbara W Trautner; Venkat Ramanathan; Rabih O Darouiche
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

3.  Functional, biophysical, and structural bases for antibacterial activity of tigecycline.

Authors:  Matthew W Olson; Alexey Ruzin; Eric Feyfant; Thomas S Rush; John O'Connell; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.

Authors:  Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Alberto Licci; Matteo De Fusco; Mauro Provinciali; Vittorio Saba; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Pharmacokinetic profile of tigecycline in serum and skin blister fluid of healthy subjects after multiple intravenous administrations.

Authors:  Heather K Sun; Christine T Ong; Ambreen Umer; Dawn Harper; Steven Troy; Charles H Nightingale; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

6.  Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.

Authors:  Issam Raad; Hend Hanna; Ying Jiang; Tanya Dvorak; Ruth Reitzel; Gassan Chaiban; Robert Sherertz; Ray Hachem
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

7.  Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing.

Authors:  Robin K Pettit; Christine A Weber; Melissa J Kean; Holger Hoffmann; George R Pettit; Rui Tan; Kelly S Franks; Marilyn L Horton
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

8.  Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.

Authors:  Carmela T M Mascio; Jeff D Alder; Jared A Silverman
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

9.  Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis.

Authors:  Juan C Martínez-Pastor; Ernesto Muñoz-Mahamud; Félix Vilchez; Sebastián García-Ramiro; Guillem Bori; Josep Sierra; José A Martínez; Lluis Font; Josep Mensa; Alex Soriano
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

10.  Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.

Authors:  Pierre Vaudaux; Bénédicte Fleury; Asllan Gjinovci; Elzbieta Huggler; Manuela Tangomo-Bento; Daniel P Lew
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.